![Pharmaceutics | Free Full-Text | Safe and Effective Cynomolgus Monkey GLP—Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders | HTML Pharmaceutics | Free Full-Text | Safe and Effective Cynomolgus Monkey GLP—Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-00200/article_deploy/html/images/pharmaceutics-14-00200-g003.png)
Pharmaceutics | Free Full-Text | Safe and Effective Cynomolgus Monkey GLP—Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders | HTML
![Frontiers | IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells Frontiers | IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells](https://www.frontiersin.org/files/Articles/676141/fimmu-12-676141-HTML/image_m/fimmu-12-676141-t001.jpg)
Frontiers | IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells
![Quantifying and Mitigating Motor Phenotypes Induced by Antisense Oligonucleotides in the Central Nervous System | bioRxiv Quantifying and Mitigating Motor Phenotypes Induced by Antisense Oligonucleotides in the Central Nervous System | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/02/15/2021.02.14.431096/F2.large.jpg)
Quantifying and Mitigating Motor Phenotypes Induced by Antisense Oligonucleotides in the Central Nervous System | bioRxiv
![Interleukin-1 alpha and high mobility group box-1 secretion in polyinosinic:polycytidylic-induced colorectal cancer cells occur via RIPK1-dependent mechanism and participate in tumourigenesis | SpringerLink Interleukin-1 alpha and high mobility group box-1 secretion in polyinosinic:polycytidylic-induced colorectal cancer cells occur via RIPK1-dependent mechanism and participate in tumourigenesis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12079-022-00681-3/MediaObjects/12079_2022_681_Fig1_HTML.png)
Interleukin-1 alpha and high mobility group box-1 secretion in polyinosinic:polycytidylic-induced colorectal cancer cells occur via RIPK1-dependent mechanism and participate in tumourigenesis | SpringerLink
![Interleukin-1 alpha and high mobility group box-1 secretion in polyinosinic:polycytidylic-induced colorectal cancer cells occur via RIPK1-dependent mechanism and participate in tumourigenesis | SpringerLink Interleukin-1 alpha and high mobility group box-1 secretion in polyinosinic:polycytidylic-induced colorectal cancer cells occur via RIPK1-dependent mechanism and participate in tumourigenesis | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12079-022-00681-3/MediaObjects/12079_2022_681_Fig5_HTML.png)
Interleukin-1 alpha and high mobility group box-1 secretion in polyinosinic:polycytidylic-induced colorectal cancer cells occur via RIPK1-dependent mechanism and participate in tumourigenesis | SpringerLink
![Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-021-00537-1/MediaObjects/41582_2021_537_Fig1_HTML.png)
Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology
![CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy - Morales - 2011 - The Journal of Pathology - Wiley Online Library CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy - Morales - 2011 - The Journal of Pathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/93e202c9-137f-4b1e-a2f2-d0aee6054d6b/mfig006.jpg)
CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy - Morales - 2011 - The Journal of Pathology - Wiley Online Library
![PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR). - Abstract - Europe PMC PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR). - Abstract - Europe PMC](https://europepmc.org/articles/PMC5596557/bin/cddis2017369f4.jpg)
PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR). - Abstract - Europe PMC
![Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy | Nature Communications Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-020-15067-5/MediaObjects/41467_2020_15067_Fig1_HTML.png)
Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy | Nature Communications
![Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21 | Nature Chemical Biology Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21 | Nature Chemical Biology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnchembio.536/MediaObjects/41589_2011_Article_BFnchembio536_Fig2_HTML.jpg)
Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21 | Nature Chemical Biology
![Cardiac Insulin-Resistance and Decreased Mitochondrial Energy Production Precede the Development of Systolic Heart Failure After Pressure-Overload Hypertrophy | Circulation: Heart Failure Cardiac Insulin-Resistance and Decreased Mitochondrial Energy Production Precede the Development of Systolic Heart Failure After Pressure-Overload Hypertrophy | Circulation: Heart Failure](https://www.ahajournals.org/cms/asset/6e356681-c3a7-4512-b26e-0a63668623e7/1039fig05.jpeg)